{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:39:41Z","timestamp":1784932781321,"version":"3.55.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871052"],"award-info":[{"award-number":["81871052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171503"],"award-info":[{"award-number":["82171503"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Vortioxetine is a serotonin reuptake inhibitor and serotonin receptor modulator used for the treatment of major depressive disorder, but recent studies have also reported anticancer effects in models of glioblastoma. Given the well-established benefits of drug repositioning, we examined the pharmacological mechanism for these anticancer actions using bioinformatics and molecular docking.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Putative molecular targets for vortioxetine were identified by searching DrugBank, GeneCards, SwissTargetPrediction, Comparative Toxicogenomics Database, and SuperPred databases, while glioblastoma-related proteins were identified using GeneCards, Online Mendelian Inheritance in Man; , and Therapeutic Target Database . A protein\u2013protein interaction (PPI) network was constructed from vortioxetine targets also involved in glioblastoma to identify core (hub) targets, which were then characterized by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses using database for annotation, visualization, and integrated discovery. Cytoscape was utilized to generate a drug-pathway-target-disease network, and molecular docking simulations were performed to evaluate direct interactions between vortioxetine and core target proteins.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 234 unique vortioxetine protein targets were identified. Among 234 vortioxetine targets identified, 48 were also related to glioblastoma. Topological analysis of the PPI network revealed 5 core targets: the serine\/threonine kinase AKT1, transcription factor hypoxia-inducible factor (HIF)-1, cell adhesion molecule cadherin-E, NF-\u03baB subunit p105, and prostaglandin-endoperoxide synthase 2. According to GO and KEGG pathway analyses, the anticancer efficacy of vortioxetine may be mediated by effects on glucose metabolism, cell migration, phosphorylation, inflammatory responses, apoptosis, and signaling via Rap1, chemical carcinogenesis-reactive oxygen species, and HIF-1. Molecular docking revealed moderately strong affinities between vortioxetine and 4 core targets.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study suggests that vortioxetine may inhibit glioblastoma development through direct effects on multiple targets and further emphasizes the value of bioinformatics analyses for drug repositioning.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ijnp\/pyaf029","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T06:12:07Z","timestamp":1746166327000},"source":"Crossref","is-referenced-by-count":6,"title":["Molecular targets of vortioxetine mediating glioblastoma suppression revealed by gene and protein network analyses and molecular docking simulations"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3793-550X","authenticated-orcid":false,"given":"Chuanjun","family":"Zhuo","sequence":"first","affiliation":[{"name":"Computational Biology and Computational Psychiatry Center (CBCP), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Medical University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]},{"name":"Laboratory of Psychiatric-Neuroimaging-Genetic and Co-morbidity (PGNP_Lab), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[{"name":"Computational Biology and Computational Psychiatry Center (CBCP), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Medical University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]},{"name":"Laboratory of Psychiatric-Neuroimaging-Genetic and Co-morbidity (PGNP_Lab), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Computational Biology and Computational Psychiatry Center (CBCP), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Medical University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]},{"name":"Laboratory of Psychiatric-Neuroimaging-Genetic and Co-morbidity (PGNP_Lab), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[{"name":"Computational Biology and Computational Psychiatry Center (CBCP), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Medical University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]},{"name":"Laboratory of Psychiatric-Neuroimaging-Genetic and Co-morbidity (PGNP_Lab), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Computational Biology and Computational Psychiatry Center (CBCP), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Medical University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]},{"name":"Laboratory of Psychiatric-Neuroimaging-Genetic and Co-morbidity (PGNP_Lab), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximing","family":"Chen","sequence":"additional","affiliation":[{"name":"Computational Biology and Computational Psychiatry Center (CBCP), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Medical University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]},{"name":"Laboratory of Psychiatric-Neuroimaging-Genetic and Co-morbidity (PGNP_Lab), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Ma","sequence":"additional","affiliation":[{"name":"Computational Biology and Computational Psychiatry Center (CBCP), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Medical University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]},{"name":"Laboratory of Psychiatric-Neuroimaging-Genetic and Co-morbidity (PGNP_Lab), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranli","family":"Li","sequence":"additional","affiliation":[{"name":"Computational Biology and Computational Psychiatry Center (CBCP), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Medical University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]},{"name":"Laboratory of Psychiatric-Neuroimaging-Genetic and Co-morbidity (PGNP_Lab), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Wang","sequence":"additional","affiliation":[{"name":"Computational Biology and Computational Psychiatry Center (CBCP), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Medical University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]},{"name":"Laboratory of Psychiatric-Neuroimaging-Genetic and Co-morbidity (PGNP_Lab), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Tian","sequence":"additional","affiliation":[{"name":"Computational Biology and Computational Psychiatry Center (CBCP), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Medical University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]},{"name":"Laboratory of Psychiatric-Neuroimaging-Genetic and Co-morbidity (PGNP_Lab), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University , Tianjin ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"2025060907364092300_CIT0001","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","article-title":"A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity","volume":"180","author":"Jacob","year":"2020","journal-title":"Cell."},{"key":"2025060907364092300_CIT0002","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","article-title":"Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions","volume":"22","author":"Wen","year":"2020","journal-title":"Neuro Oncol."},{"key":"2025060907364092300_CIT0003","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/B978-0-12-802997-8.00023-2","article-title":"Glioblastoma","volume":"134","author":"Wirsching","year":"2016","journal-title":"Handb Clin Neurol."},{"key":"2025060907364092300_CIT0004","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11060-011-0738-7","article-title":"Improved survival time trends for glioblastoma using the SEER 17 population-based registries","volume":"107","author":"Koshy","year":"2012","journal-title":"J Neurooncol."},{"key":"2025060907364092300_CIT0005","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","article-title":"Glioblastoma and other primary brain malignancies in adults: a review","volume":"329","author":"Schaff","year":"2023","journal-title":"JAMA."},{"key":"2025060907364092300_CIT0006","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"key":"2025060907364092300_CIT0007","doi-asserted-by":"publisher","first-page":"v1v1","DOI":"10.1093\/neuonc\/now207","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013","volume":"18","author":"Ostrom","year":"2016","journal-title":"Neuro Oncol"},{"key":"2025060907364092300_CIT0008","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3978\/j.issn.2305-5839.2015.05.10","article-title":"Current trends in the surgical management and treatment of adult glioblastoma","volume":"3","author":"Young","year":"2015","journal-title":"Ann Transl Med."},{"key":"2025060907364092300_CIT0009","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fphar.2018.00218","article-title":"Drug repositioning in glioblastoma: a pathway perspective","volume":"9","author":"Tan","year":"2018","journal-title":"Front Pharmacol."},{"key":"2025060907364092300_CIT0010","doi-asserted-by":"publisher","first-page":"10","DOI":"10.17912\/micropub.biology.001173","article-title":"An anti-depressant drug vortioxetine suppresses malignant glioblastoma cell growth","volume":"2024","author":"Devare","year":"2024","journal-title":"MicroPubl Biol"},{"key":"2025060907364092300_CIT0011","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1038\/s41591-024-03224-y","article-title":"High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity","volume":"30","author":"Lee","year":"2024","journal-title":"Nat Med."},{"key":"2025060907364092300_CIT0012","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pharmthera.2014.07.001","article-title":"Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data","volume":"145","author":"Sanchez","year":"2015","journal-title":"Pharmacol Ther."},{"key":"2025060907364092300_CIT0013","doi-asserted-by":"crossref","first-page":"104222","DOI":"10.1016\/j.ajp.2024.104222","article-title":"Vortioxetine versus reuptake inhibitors in adults with major depressive disorder: a systematic review and meta-analysis of randomized controlled trials","volume":"101","author":"Barbosa","year":"2024","journal-title":"Asian J Psychiatr."},{"key":"2025060907364092300_CIT0014","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12991-024-00505-1","article-title":"Individualized strategies for depression: narrative review of clinical profiles responsive to vortioxetine","volume":"23","author":"Cuomo","year":"2024","journal-title":"Ann Gen Psychiatry."},{"key":"2025060907364092300_CIT0015","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/nbt1007-1110","article-title":"Network pharmacology","volume":"25","author":"Hopkins","year":"2007","journal-title":"Nat Biotechnol."},{"key":"2025060907364092300_CIT0016","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jad.2024.03.096","article-title":"Molecular mechanisms of quetiapine bidirectional regulation of bipolar depression and mania based on network pharmacology and molecular docking: evidence from computational biology","volume":"355","author":"Li","year":"2024","journal-title":"J Affect Disord."},{"key":"2025060907364092300_CIT0017","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41537-024-00504-x","article-title":"Exploring the molecular targets of fingolimod and siponimod for treating the impaired cognition of schizophrenia using network pharmacology and molecular docking","volume":"10","author":"Li","year":"2024","journal-title":"Schizophrenia (Heidelb)"},{"key":"2025060907364092300_CIT0018","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"2025060907364092300_CIT0019","doi-asserted-by":"publisher","first-page":"baq020","DOI":"10.1093\/database\/baq020","article-title":"GeneCards version 3: the human gene integrator","volume":"2010","author":"Safran","year":"2010","journal-title":"Database (Oxford)."},{"key":"2025060907364092300_CIT0020","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2025060907364092300_CIT0021","doi-asserted-by":"publisher","first-page":"D1257","DOI":"10.1093\/nar\/gkac833","article-title":"Comparative toxicogenomics database (CTD): update 2023","volume":"51","author":"Davis","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"2025060907364092300_CIT0022","doi-asserted-by":"publisher","first-page":"W26","DOI":"10.1093\/nar\/gku477","article-title":"SuperPred: update on drug classification and target prediction","volume":"42","author":"Nickel","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"2025060907364092300_CIT0023","doi-asserted-by":"publisher","first-page":"D1038","DOI":"10.1093\/nar\/gky1151","article-title":"OMIM.org: leveraging knowledge across phenotype-gene relationships","volume":"47","author":"Amberger","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2025060907364092300_CIT0024","doi-asserted-by":"publisher","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","article-title":"TTD: therapeutic target database describing target druggability information","volume":"52","author":"Zhou","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"2025060907364092300_CIT0025","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"2025060907364092300_CIT0026","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"2025060907364092300_CIT0027","doi-asserted-by":"crossref","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","article-title":"DAVID: database for annotation, visualization, and integrated discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol."},{"key":"2025060907364092300_CIT0028","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem."},{"key":"2025060907364092300_CIT0029","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"2025060907364092300_CIT0030","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/978-1-4939-7000-1_26","article-title":"Protein Data Bank (PDB): the single global macromolecular structure archive","volume":"1607","author":"Burley","year":"2017","journal-title":"Methods Mol Biol."},{"key":"2025060907364092300_CIT0031","doi-asserted-by":"publisher","first-page":"113985","DOI":"10.1016\/j.biopha.2022.113985","article-title":"The application of antidepressant drugs in cancer treatment","volume":"157","author":"Zheng","year":"2023","journal-title":"Biomed Pharmacother."},{"key":"2025060907364092300_CIT0032","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1158\/0008-5472.CAN-18-2738","article-title":"AKT as a therapeutic target for cancer","volume":"79","author":"Song","year":"2019","journal-title":"Cancer Res."},{"key":"2025060907364092300_CIT0033","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13045-021-01137-8","article-title":"Targeting Akt in cancer for precision therapy","volume":"14","author":"Hua","year":"2021","journal-title":"J Hematol Oncol."},{"key":"2025060907364092300_CIT0034","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1038\/onc.2008.170","article-title":"AKT1(E17K) in human solid tumours","volume":"27","author":"Bleeker","year":"2008","journal-title":"Oncogene."},{"key":"2025060907364092300_CIT0035","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.7150\/jca.60596","article-title":"Co-overexpression of RIOK1 and AKT1 as a prognostic risk factor in glioma","volume":"12","author":"Wang","year":"2021","journal-title":"J Cancer."},{"key":"2025060907364092300_CIT0036","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s00432-024-05972-3","article-title":"Euphorbia helioscopia L. extract suppresses hepatitis B virus-related hepatocellular carcinoma via alpha serine\/threonine-protein kinase and Caspase-3","volume":"150","author":"Xiong","year":"2024","journal-title":"J Cancer Res Clin Oncol."},{"key":"2025060907364092300_CIT0037","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s11064-016-2044-4","article-title":"AKT\/GSK3\u03b2 signaling in glioblastoma","volume":"42","author":"Majewska","year":"2017","journal-title":"Neurochem Res."},{"key":"2025060907364092300_CIT0038","doi-asserted-by":"publisher","first-page":"12608","DOI":"10.3390\/ijms222212608","article-title":"Hypoxia: the cornerstone of glioblastoma","volume":"22","author":"Dom\u00e8nech","year":"2021","journal-title":"Int J Mol Sci ."},{"key":"2025060907364092300_CIT0039","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1152\/physiol.00001.2004","article-title":"Hydroxylation of HIF-1: oxygen sensing at the molecular level","volume":"19","author":"Semenza","year":"2004","journal-title":"Physiol. J."},{"key":"2025060907364092300_CIT0040","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emm.2004.1","article-title":"Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions","volume":"36","author":"Lee","year":"2004","journal-title":"Exp Mol Med."},{"key":"2025060907364092300_CIT0041","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/CEJ.0000000000000824","article-title":"CDH1 hypermethylation: a potential molecular pathway for invasiveness in glioblastoma","volume":"33","author":"Belut","year":"2024","journal-title":"Eur J Cancer Prev."},{"key":"2025060907364092300_CIT0042","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13058-023-01731-3","article-title":"The chromatin architectural regulator SND1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene methylation","volume":"25","author":"Zhang","year":"2023","journal-title":"Breast Cancer Res."},{"key":"2025060907364092300_CIT0043","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/PPO.0000000000000279","article-title":"The roles of DNA Methylation in the stages of cancer","volume":"23","author":"McMahon","year":"2017","journal-title":"Cancer J."},{"key":"2025060907364092300_CIT0044","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/febs.13627","article-title":"NFKB1: a suppressor of inflammation, ageing and cancer","volume":"283","author":"Cartwright","year":"2016","journal-title":"FEBS J."},{"key":"2025060907364092300_CIT0045","doi-asserted-by":"publisher","first-page":"293","DOI":"10.5114\/fn.2024.135983","article-title":"Long non-coding RNA LBX2-AS1 activates IL4R to promote glioblastoma metastasis and angiogenesis by binding to the transcription factor NFKB1","volume":"62","author":"Li","year":"2024","journal-title":"Folia Neuropathol."},{"key":"2025060907364092300_CIT0046","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3390\/cancers13051111","article-title":"Integrin \u03b1v\u03b23 engagement regulates glucose metabolism and migration through focal adhesion kinase (FAK) and protein arginine methyltransferase 5 (PRMT5) in glioblastoma cells","volume":"13","author":"Che","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2025060907364092300_CIT0047","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12964-024-01602-0","article-title":"Programmed cell death disrupts inflammatory tumor microenvironment (TME) and promotes glioblastoma evolution","volume":"22","author":"Liang","year":"2024","journal-title":"Cell Commun Signal."},{"key":"2025060907364092300_CIT0048","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.lfs.2011.12.010","article-title":"Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1\/Rap1 pathways","volume":"90","author":"Moon","year":"2012","journal-title":"Life Sci."},{"key":"2025060907364092300_CIT0049","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1242\/jcs.135988","article-title":"A crucial role for DOK1 in PDGF-BB-stimulated glioma cell invasion through p130Cas and Rap1 signalling","volume":"127","author":"Barrett","year":"2014","journal-title":"J Cell Sci."},{"key":"2025060907364092300_CIT0050","doi-asserted-by":"publisher","first-page":"122904","DOI":"10.1016\/j.biomaterials.2024.122904","article-title":"Amplifying glioblastoma immunotherapy: T cell shielding through Nitric oxide\/reactive oxygen species scavenging nanoparticles Potentiates anti-PD-1","volume":"315","author":"Lee","year":"2025","journal-title":"Biomaterials."},{"key":"2025060907364092300_CIT0051","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s13046-023-02927-3","article-title":"AMPK-HIF-1\u03b1 signaling enhances glucose-derived de novo serine biosynthesis to promote glioblastoma growth","volume":"42","author":"Yun","year":"2023","journal-title":"J Exp Clin Cancer Res."},{"key":"2025060907364092300_CIT0052","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12967-015-0758-8","article-title":"Cycling hypoxia induces chemoresistance through the activation of reactive oxygen species-mediated B-cell lymphoma extra-long pathway in glioblastoma multiforme","volume":"13","author":"Chen","year":"2015","journal-title":"J Transl Med."}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijnp\/advance-article-pdf\/doi\/10.1093\/ijnp\/pyaf029\/63039847\/pyaf029.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/advance-article-pdf\/doi\/10.1093\/ijnp\/pyaf029\/63039847\/pyaf029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/advance-article-pdf\/doi\/10.1093\/ijnp\/pyaf029\/63039847\/pyaf029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T11:36:50Z","timestamp":1749469010000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/doi\/10.1093\/ijnp\/pyaf029\/8123668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyaf029","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,5,2]]},"article-number":"pyaf029"}}